Roza Motavalli
- Immunology top 5%
- Reproductive System and Pregnancy 10
- Oncology top 5%
- CAR-T cell therapy research 6
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies 6
- Nephrology top 10%
- Renal Diseases and Glomerulopathies 5
-
- Extracellular vesicles in disease 6
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
-
- Pregnancy and Medication Impact 4
- Co-authors
- Farhad Motavalli KhiaviFaroogh MarofiMehdi YousefiAlexei Valerievich YumashevMostafa JarahianMax Stanley ChartrandYashwant PathakLakshmi Thangavelu
- Journals
- SHILAP Revista de lepidopterología (1 paper)Life Sciences (2 papers)Cancer Science (1 paper)
In The Last Decade
Roza Motavalli
43 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 477
- Oncology 539
- Obstetrics and Gynecology 80
- Nephrology 71
- Molecular Biology 374
Countries citing papers authored by Roza Motavalli
This map shows the geographic impact of Roza Motavalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roza Motavalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roza Motavalli more than expected).
Fields of papers citing papers by Roza Motavalli
This network shows the impact of papers produced by Roza Motavalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roza Motavalli. The network helps show where Roza Motavalli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roza Motavalli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 91 | |
| 11 | 2021 | 25 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 51 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 12 | |
| 18 | CAR T cells in solid tumors: challenges and opportunitiesbreakdown → | 2021 | 395 |
| 19 | 2020 | 3 | |
| 20 | 2019 | 24 |
About Roza Motavalli
Roza Motavalli is a scholar working on Obstetrics and Gynecology, Nephrology and Immunology, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (10 papers), Pregnancy and preeclampsia studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Extracellular vesicles in disease (6 papers), CAR-T cell therapy research (6 papers), COVID-19 Clinical Research Studies (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Pregnancy and Medication Impact (4 papers). The work is most often cited by research in Immunology (477 citations), Oncology (539 citations) and Obstetrics and Gynecology (80 citations). Roza Motavalli has collaborated with scholars based in Iran, Russia and Sweden. Frequent co-authors include Farhad Motavalli Khiavi, Faroogh Marofi, Mehdi Yousefi, Alexei Valerievich Yumashev, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Lakshmi Thangavelu, Safa Tahmasebi and Navid Shomali. Their work appears in journals such as SHILAP Revista de lepidopterología, Life Sciences and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.